ClinicalTrials.govpublic full text
Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)
ovarian cancer, fallopian tube cancer, peritoneal cancer, ariel3, ariel 3, platinum sensitive, parp inhibitor, rucaparib, homologous recombination, homologous recombination deficiency, co-338, pf 01367338
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 908850
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.